Product

TDM-105795

Aliases

TDM-105795, 0.0025%, TDM-105795, 0.02%, TDM-105795 topical vehicle solution

2 clinical trials

1 drug

2 indications

Indication

Indication

Drug

Clinical trial

A Randomized, Double-blind, Vehicle-controlled, Parallel Group, Multi-dose Study to Evaluate the Efficacy and Safety of TDM-105795 in Male Subjects With Androgenetic Alopecia

Status: Completed, Estimated PCD: 2023-11-08

Clinical trial

A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group, Multi-Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TDM-105795 in Healthy Male Subjects With Androgenetic Alopecia (AGA)

Status: Completed, Estimated PCD: 2022-11-15